<DOC>
	<DOCNO>NCT00751075</DOCNO>
	<brief_summary>This study conduct compare effectiveness safety mometasone nasal spray daily twice daily amoxicillin placebo treat sign symptom acute rhinosinusitis . Patients receive mometasone nasal spray 2 spray per nostril daily , 2 spray per nostril twice daily , amoxicillin 500 mg three time day , placebo three time day . Patients nasal spray treat 15 day patient amoxicillin placebo treat 10 day . All patient followed-up 14-day no-treatment observation period .</brief_summary>
	<brief_title>Effectiveness Safety Once Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo Treatment Acute Rhinosinusitis ( Phase 3 Study ) ( Study P02692 )</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Subjects must : diagnose acute rhinosinusitis sign symptom rhinosinusitis least 7 28 day prior Baseline major symptom score &gt; =5 &lt; =12 Screening Baseline , 3 5 major individual symptom rat `` severe '' &gt; =12 year old good health overall normal laboratory test pregnant , intend become pregnant intending impregnate . Subjects : history chronic rhinosinusitis undergone sinus nasal surgery chronic rhinosinusitis 6 month prior Screening fever &gt; =101Â°F and/or persistent severe unilateral facial pain/tooth pain ; and/or orbital periorbital facial swelling ; and/or dental involvement ; and/or worsen symptoms initial improvement history symptomatic seasonal allergic rhinitis expose allergenic pollen asthma FEV1 &lt; 65 % predict volume past 3 month exacerbation within past 30 day nasal polyp , Kartagener 's syndrome , otitis atrophic rhinitis certain comorbid condition contraindication certain drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>